The Global Fund invests US$4 billion a year to defeat HIV, TB and malaria and therefore to ensure a healthier, safer, equitable future for all. To achieve these goals, it works with national governments and international partners, such as the WHO and World Bank. It also uses a range of Innovative financial instruments.
To explain its work, the Strategy, Investment and Impact team commissioned Eyetalk to write several case studies. We spoke with experts at the Global Fund, World Bank, and elsewhere, then synthesised the information into roughly 5,000 word reports.